IP Library › Granted Patent US 9,938,554
Granted Patent B2
US 9,938,554 · App. 15/309,869 · Granted Apr 10, 2018

Co-cultivation of propionibacterium and yeast

Inventors: Mirjan Svagelj (Ljubljana, SI); Stefan Fujs (Ljubljana, SI); Gregor Kosec (Ljubljana, SI); Hrvoje Petkovic (Ljubljana, SI)
Assignees: Acies Bio d.o.o.; Arima d.o.o
C12P39/00C12N1/16C12P19/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,554
App. No.
15/309,869
Granted
Apr 10, 2018
Kind
B2
Abstract

The invention provides a fungal cell, such as a yeast cell, capable of growing in co-cultivation with Propionibacterium . Also provided are methods of producing such cells and fermentation processes using the fungal cell of the invention and Propionibacterium in co-cultivation. Such co-cultivation significantly reduces the chemical oxygen demand load of the waste fermentation broth.

Claims (12)

1. A yeast cell deposited on 14 Jan. 2014 at the Deutsche Sammlung von Mikroorganismen and Zellkulturen (DSMZ), Braunschweig, Germany, and available under accession number DSM 28271.

2. A fungal cell capable of growing in a stationary-phase supernatant of a propionibacterium cultivation at a maximum growth rate (μ max ) of at least 0.02 h −1 wherein said stationary-phase supernatant is obtained from a stationary culture of Propionibacterium freudenreichii cultivated without aeration at 35° C. in a liquid medium consisting of 60 g/L sweet whey powder, 5 g/L yeast extract, and 40 mg/L calcium D-pantothenate in water.

3. The fungal cell of claim 2 , wherein the fungal cell is a yeast cell.

4. A process for producing a biotechnological product, said process comprising co-cultivation of propionibacterium and the fungal cell of claim 2 in a cultivation medium.

5. The process of claim 4 , wherein said biotechnological product is produced by said propionibacterium.

6. The process of claim 4 , wherein said biotechnological product is vitamin B12.

7. The process of claim 4 , wherein said process includes a phase without aeration followed by an aerobic phase.

8. The process of claim 4 , wherein at least 90% of the growth of the propionibacterium occurs during the phase without aeration.

9. The process of claim 4 , wherein at least 90% of the growth of the fungal cell occurs during the aerobic phase.

10. The process of claim 4 , wherein the chemical oxygen demand (COD) of the medium is reduced to a level of equal to or less than 25% of the initial COD of the cultivation medium.

11. The process of claim 4 , wherein said cultivation medium comprises whey.

12. The process of claim 4 , wherein the chemical oxygen demand (COD) of the medium is reduced to a level of equal to or less than 10% of the initial COD of the cultivation medium.

Priority Claims (1)
EP 14167774 · May 9, 2014 · regional
Continuity (1)
Related Publication 20170145467A1 · May 25, 2017